Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FluBlok Efficacy and Lot Consistency in Healthy Adults
NCT00539981Phase 3Completed
- Sponsor
- Sanofi
- Start
- Sep 2007
- Primary completion
- May 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in influenza comparing FluBlok with Placebo (2 arms). Primary endpoints: Number of Participants Reporting Solicited Injection Site (Local) Reactions at 7 days, Number of Participants Reporting Solicited Systemic Reactions at 7 days and 3 more. Started Sep 2007; status: completed.
02
Drugs
Quadrivalent recombinant influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00539981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00539981.